Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News OncoSec Medical Inc ONCSQ

Healthcare Biotechnology
OncoSec Medical Incorporated is a late-stage immuno-oncology company. The Company is focused on designing, developing and commercializing intra-tumoral DNA-based therapeutics delivered by electroporation (EP) to stimulate and augment anti-tumor immune responses for the treatment of cancers. Its core technology, ImmunoPulse, is a drug-device therapeutic modality platform comprised of an OncoSec... see more

Recent & Breaking News (GREY:ONCSQ)

OncoSec Medical Issues Annual Letter To Shareholders

Business Wire June 12, 2014

OncoSec Medical Closes $16 Million Registered Direct Offering

Business Wire June 10, 2014

Advanced Cell Technology To Host Conference Call On June 9th

Accesswire June 6, 2014

OncoSec Medical Announces $16 Million Registered Direct Offering

Business Wire June 4, 2014

OncoSec Medical to Present at LD Micro 4th Invitational

Business Wire June 3, 2014

Easton Pharmaceuticals, Inc. To Purchase An Interest In Pending Medical Marijuana Operation

Accesswire June 2, 2014

OncoSec Medical Presents Positive Phase 2 Interim Data Evaluating ImmunoPulse in Melanoma

Business Wire June 2, 2014

Nuvilex And TD2 Begin Studies Related To Unbearable Pain Side Effect

Accesswire May 28, 2014

OncoSec Medical To Present at Four Events in June

Business Wire May 27, 2014

GACR Sees Share Volume Surge After Release Of First Quarter Financial Results

Accesswire May 23, 2014

OncoSec Medical Inc. To Be Featured Presenter At 3rd Annual Marcum MicroCap Conference

Accesswire May 16, 2014

OncoSec Medical To Present At The Third Annual Marcum MicroCap Conference

PR Newswire May 13, 2014

Xstelos Holdings Inc. Sees Surge in Volume Despite Lack of News

Accesswire May 7, 2014

OncoSec Medical Presents New Data at 10th Annual PEGS: The Essential Protein Engineering Summit in Boston

Business Wire May 5, 2014

OncoSec Medical to Present at Seven Events in May

Business Wire April 28, 2014

OncoSec Medical Names Adil Daud, M.D. as Chief Clinical Strategist

Business Wire April 23, 2014

OncoSec Medical Appoints New Executive Director of Research and Development

Accesswire April 22, 2014

OncoSec Medical Selected to Present Phase II Data in Poster Highlights Session at 2014 ASCO Annual Meeting

Business Wire April 22, 2014

OncoSec Medical Appoints Jean S. Campbell, Ph.D. as Executive Director of Research and Development

Business Wire April 21, 2014

Elite Pharmaceuticals to Receive up to 40 Million from Lincoln Park Capital Fund

Accesswire April 15, 2014